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Sir,
In a recent paper in the British Journal of Cancer, Hussain et al
(2007) found carbonic anhydrase IX expression to be related to a
poor prognosis in 144 unselected breast cancer patients. They
state: ‘CA IX expression may contribute to the identification of
patients at greater risk of relapse who should be offered adjuvant
treatment while sparing those whose prognosis is already good.’
However, in their patient description, Hussain et al. do not give
any information concerning whether adjuvant treatment was given
to these patients and, if so, which type of treatment. This makes the
data difficult to interpret. We have earlier described the interac-
tions of CA IX expression with both adjuvant endocrine and
chemotherapy in 253 breast cancer patients (Span et al 2003). CA
IX is induced by hypoxia inducible factor (HIF)-1, and is
particularly overexpressed in VHL-related clear-cell renal carcino-
ma. Hypoxia itself is known to be associated with a poor response
to radio- and chemotherapy. This indicates that CAIX expression
is not prognostic – being associated with disease progression
irrespective of treatment – but rather predictive, –predicting which
patients will benefit from adjuvant treatment and who will not.
As such, we disagree with the authors’ statement that CA IX
expression will identify patient who should be offered adjuvant
treatment due to a poor prognosis. Rather, more aggressive
treatment or alternative treatment modalities might be offered to
patients with high CA IX expression in their breast tumours, as the
available data indicate that radiotherapy, endocrine and chemo-
therapy will be less successful for them than for patients with low
CA IX expression.
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